Fortress Biotech Pref Preferred Stock Analysis

Fortress Preferred Stock Analysis Notes

The company recorded a loss per share of 0.86. Fortress Biotech Pref last dividend was issued on the 14th of February 2023. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people. To learn more about Fortress Biotech Pref call Lindsay Rosenwald at 781 652 4500 or check out https://www.fortressbiotech.com.

Fortress Biotech Pref Investment Alerts

Fortress Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 107.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fortress Biotech's market, we take the total number of its shares issued and multiply it by Fortress Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Fortress Profitablity

The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.63.

Technical Drivers

As of the 14th of February 2026, Fortress Biotech shows the Downside Deviation of 2.53, mean deviation of 2.72, and Coefficient Of Variation of 539.52. Fortress Biotech Pref technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fortress Biotech Pref Price Movement Analysis

Fortress Biotech Outstanding Bonds

Fortress Biotech Predictive Daily Indicators

Fortress Biotech Forecast Models

Fortress Biotech's time-series forecasting models are one of many Fortress Biotech's preferred stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fortress Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Fortress Biotech Pref Debt to Cash Allocation

Fortress Biotech Pref has accumulated 46.56 M in total debt with debt to equity ratio (D/E) of 0.81, which is about average as compared to similar companies. Fortress Biotech Pref has a current ratio of 2.79, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Fortress Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Fortress Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fortress Biotech Pref sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fortress to invest in growth at high rates of return. When we think about Fortress Biotech's use of debt, we should always consider it together with cash and equity.

Fortress Biotech Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Fortress Biotech's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Fortress Biotech, which in turn will lower the firm's financial flexibility.

Fortress Biotech Corporate Bonds Issued

Preferred Stock analysis is the technique used by a trader or investor to examine and evaluate how Fortress Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fortress shares will generate the highest return on investment. We also built our preferred stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Preferred Stock such as Fortress Biotech. By using and applying Fortress Preferred Stock analysis, traders can create a robust methodology for identifying Fortress entry and exit points for their positions.

When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.